NIH Clinical Research Studies Listed By Institute of the Principal Investigator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

22 Protocols (20 Active Accrual of new subjects, 2 Follow-up of previously enrolled subjects)

Active Accrual, Protocols Recruiting New Patients 
* 04-AR-0205:
Progression of Spinal Fusion in Ankylosing Spondylitis

* 03-AR-0298:
A Pilot Study with the IL-1 Receptor Antagonist Anakinra/Kineret in Patients with Neonatal Onset Multisystem Inflammatory Disease (NOMID/CINCA Syndrome)

* 03-AR-0208:
A 24-week, Double Blind, Randomized Study to Determine the Effects of 24 Weeks of Dosing with Tripterygium Wilfordii Hook F (TwHF) or Sulfasalazine, in Subjects with Active Rheumatoid Arthritis

* 03-AR-0173:
Studies of the Pathogenesis and Natural History of Neonatal Onset Multisystem Inflammatory Disease (NOMID)

* 03-AR-0133:
Clinically Important Changes in Rheumatoid Arthritis

* 03-AR-0131:
Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study

* 03-AR-0130:
Genetic Determinants of Ankylosing Spondylitis Severity - Cross Sectional Study

* 02-AR-0272:
A Phase I, Open-Labeled, Dose-Ascending Clinical Trial of Immunotherapy of MRA, A Humanized Anti-IL 6 Receptor Monoclonal Antibody, In Patients with Systemic Lupus Erythematosus

* 02-AR-0267:
Role of the Antibody Against NR2 Glutamate Receptor in Cognitive Dysfunction in Patients with Systemic Lupus Erythematosus

* 02-AR-0170:
Suppression of the Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis in Women with Rheumatoid Arthritis

* 02-AR-0156:
A Randomized, Double-Blind, Placebo-Controlled Trial of Infliximab In Patients With Dermatomyositis and Polymyositis

* 02-AR-0131:
Collection Of Blood Components Using Apheresis From Patients With Rheumatic Diseases And Healthy Volunteers

* 02-AR-0081:
A Randomized Double Blind Controlled Intra-Patient Dose Escalation Phase II Trial of Infliximab in Pediatric Patients with Refractory Juvenile Rheumatoid Arthritis

* 01-AR-0227:
Natural History of Rheumatic Disease in Minority Communities

* 00-AR-0222:
Studies of the Pathogenesis and Natural History of Arthritis and Related Conditions

* 99-AR-0004:
Molecular Basis of Primary Immunodeficiencies

* 95-AR-0082:
Studies of the Pathogenesis and Natural History of Psoriatic Arthritis

* 94-AR-0105:
Genetics and Pathophysiology of Familial Mediterranean Fever and Related Disorders

* 94-AR-0066:
Studies of the Pathogenesis and Natural History of Systemic Lupus Erythematosus (SLE)

* 91-AR-0196:
Studies on the Natural History and Pathogenesis of Polymyositis, Dermatomyositis, and Related Diseases

Active Follow-up, Protocols NOT Recruiting New Patients 

* 00-AR-0220:
Randomized Double Blind Active Treatment Controlled Trial of the Anti-TNF-Alpha Antibody Infliximab in Patients with Erosive Rheumatoid Arthritis

* 98-AR-0124:
Genetics of Rheumatoid Arthritis: The North American Rheumatoid Arthritis Consortium

Command Menu Bar

Search The Studies | Help | Questions |
Clinical Center Home | NIH Home

Clinical Center LogoWarren Grant Magnuson Clinical Center (CC)
National Institutes of Health (NIH)
Bethesda, Maryland 20892. Last update: 10/14/2004
Search The Studies Help Questions
Search The Studies Help Questions